BioCentury
ARTICLE | Company News

HTG Molecular Diagnostics, Merck KGaA deal

October 17, 2016 7:00 AM UTC

The companies partnered to develop companion diagnostics alongside Merck drugs. The initial program will utilize the HTG EdgeSeq DLBCL Cell of Origin Assay with Merck’s M7583, a selective and irrevers...